AKYNZEO

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Oct 10, 2014

   11 yr 10 mo ago

2. Today

3. Patent 11559523 expires

   Listed drug product patent expiration.

   Nov 18, 2030

   in 4 yr 6 mo

4. Patent 12042494 expires

   Listed drug product patent expiration.

   Nov 18, 2030

   in 4 yr 6 mo

5. Patent 8623826 expires

   Listed method-of-use patent (U-2293) expiration.

   Nov 18, 2030

   in 4 yr 6 mo

6. Patent 8951969 expires

   Listed drug product patent expiration.

   Nov 18, 2030

   in 4 yr 6 mo

7. Patent 9186357 expires

   Listed method-of-use patent (U-2293) expiration.

   Nov 18, 2030

   in 4 yr 6 mo

8. Patent 9943515 expires

   Listed method-of-use patent (U-2293) expiration.

   Nov 18, 2030

   in 4 yr 6 mo

9. Patent 10828297 expires

   Listed method-of-use patent (U-2293) expiration.

   Dec 17, 2030

   in 4 yr 7 mo

10. Patent 9271975 expires

    Listed method-of-use patent (U-2293) expiration.

    Sep 09, 2031

    in 5 yr 4 mo

11. Patent 10233154 expires

    Listed drug substance patent expiration.

    Sep 25, 2035

    in 9 yr 5 mo

12. Patent 10676440 expires

    Listed drug substance patent expiration.

    Sep 25, 2035

    in 9 yr 5 mo

13. Patent 10961195 expires

    Listed drug substance patent expiration.

    Sep 25, 2035

    in 9 yr 5 mo

14. Patent 9951016 expires

    Listed drug substance patent expiration.

    Sep 25, 2035

    in 9 yr 5 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (12)